Fina Biosolutions has been issued European patent No. 3099800, Expression and Purification of CRM Proteins and Related Proteins, and Protein Domains. The patent covers expression of the conjugate vaccine carrier protein CRM197 in our E. coli strain engineered to have an oxidative cytoplasm. FinaBio markets the E. coli expressed CRM197 under the name EcoCRM®.
{iframe}https://www.linkedin.com/posts/andrew-lees-ph-d-a76a423_crm197-finabio-ecocrm-activity-6727746401045884928-TNaA/{/iframe}